Search
Search Results
-
Münsteraner Standard: modifizierte PAUL®-Implantation bei Zustand nach PreserFlo® MicroShunt-Implantation. Videobeitrag
Objective of surgeryThe aim of this surgical technique is the modified placement of a Paul® implant (Fa. Advanced Ophthalmic Innovations, Singapur)...
-
Intraoperative primary partial occlusion of the PreserFlo MicroShunt to prevent initial postoperative hypotony
PurposeThe aim of the underlying study was to present a new surgical method in PreserFlo MicroShunt surgery for glaucoma. A removable polyamide...
-
PRESERFLO ™ MicroShunt versus trabeculectomy: 1-year results on efficacy and safety
PurposeTo compare the efficacy and safety of the PRESERFLO™ MicroShunt versus trabeculectomy in patients with primary open-angle glaucoma (POAG)...
-
Subconjunctival filtration in evolution: current evidence on MicroShunt implantation for treating patients with glaucoma
BackgroundAlthough traditional surgical procedures for glaucoma (such as trabeculectomy and tube-shunt implantation) can significantly reduce...
-
Standard anterior peritomy versus a small posterior incision for the implantation of the PRESERFLO microshunt
PurposeTo compare two approaches for the implantation of the PRESERFLO microshunt: an anterior approach (A) with a 6–8-mm peritomy and a posterior...
-
Preserflo microshunt implant for the treatment of refractory uveitic glaucoma: 36-month outcomes
ObjectivesTo determine 36-month efficacy and safety outcomes of the PRESERFLO Microshunt implant in the treatment of refractory uveitic glaucoma.
...
-
A simple surgical solution for the treatment of persistent postoperative hypotony after PRESERFLO MicroShunt implantation
Background/ObjectivesPRESERFLO MicroShunt implantation is a relatively new and increasingly popular treatment for recalcitrant glaucoma. Though...
-
Effectiveness and cost-effectiveness of MicroShunt implantation versus standard trabeculectomy for open-angle glaucoma (a SIGHT study): study protocol of a multicentre randomised controlled trial
BackgroundTrabeculectomy is the “gold standard” initial surgical procedure for open-angle glaucoma worldwide. During the last decade, the...
-
Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation
PurposeTo report preliminary 6-month results on the use of the Preserflo Microshunt implant with and without Ologen in 50 pseudophakic eyes with...
-
Early evaluation of optic nerve head morphology and choroidal thickness after PreserFlo MicroShunt implantation
PurposeThe aim of this study is to investigate changes in choroidal and optic nerve morphological parameters following MicroShunt PreserFlo...
-
PRESERFLO MicroShunt implantation versus trabeculectomy for primary open-angle glaucoma: a two-year follow-up study
BackgroundTo compare the intermediate-term efficacy of PRESERFLO (PF) MicroShunt implantation with trabeculectomy (TE) in patients with primary...
-
Early post-operative anterior segment parameters modifications induced by PreserFlo MicroShunt in primary open-angle glaucoma
PurposeThe aim this study is to determine anterior chamber parameters variations induced by PreserFlo MicroShunt implantation, in the early...
-
Evaluation of a Novel Αb Εxterno MicroShunt for the Treatment of Glaucoma
The surgical management of glaucoma has been revolutionized by the introduction of minimally invasive glaucoma surgery (MIGS). The various MIGS...
-
Additional Guidance on the Use of the PRESERFLO™ MicroShunt in the Treatment of Glaucoma: Insights from a Second Delphi Consensus Panel
IntroductionThe PRESERFLO™ MicroShunt (PMS) has been proven to significantly lower intraocular pressure (IOP) in patients with glaucoma and has been...
-
Histopathological findings of failed blebs after microinvasive bleb surgery with the XEN Gel Stent and Preserflo MicroShunt
PurposeThe success of XEN Gel Stent (XEN) and Preserflo MicroShunt (Preserflo) implantation depends mainly on the development of bleb fibrosis. This...
-
Will the PRESERFLO™ MicroShunt impact the future of trabeculectomy practice? A UK and Éire Glaucoma Society National Survey
Background/objectivesTo explore the attitudes of UK glaucoma specialists regarding the current and future practice of trabeculectomy and the novel...
-
Intermediate-term impact on corneal endothelial cells and efficacy of Preserflo MicroShunt implantation in patients with open-angle glaucoma – a prospective study over two years
IntroductionPreserflo MicroShunt is a novel microinvasive bleb forming device for the treatment of primary open-angle glaucoma. The intermediate- and...
-
PreserFlo MicroShunt® exposure: a case series
BackgroundPreserFlo® MicroShunt (PM) (also known as InnFocus® MicroShunt) is a subconjunctival stent implanted ab externo via a minimally invasive...
-
-
Short-term safety and efficacy of Preserflo™ Microshunt in glaucoma patients: a multicentre retrospective cohort study
Background/aimsTo evaluate 1-year success rates and safety profile of Preserflo™ Microshunt in glaucoma patients.
MethodsRetrospective multicentre...
